We are live on
!
Find out more
IHM
Iguana Healthcare Management Portfolio holdings
AUM
$152M
1-Year Est. Return
48.74%
This Fund
S&P 500
This Quarter
Est. Return
+26.9%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$202M
AUM Growth
+$34.9M
(+21%)
Cap. Flow
+$7.29M
Cap. Flow
% of AUM
3.61%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
86
New
26
Increased
16
Reduced
19
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$10.7M |
| 2 |
AET
Aetna Inc
AET
|
+$6.28M |
| 3 |
Karyopharm Therapeutics
KPTI
|
+$2.94M |
| 4 |
Cardinal Health
CAH
|
+$2.36M |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$2.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$7.07M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
+$6.48M |
| 3 |
Zimmer Biomet
ZBH
|
+$4.09M |
| 4 |
Elevance Health
ELV
|
+$2.88M |
| 5 |
MZOR
Mazor Robotics Ltd.
MZOR
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.28% |
| 2 | Financials | 3.15% |
| 3 | Energy | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Elevance Health
ELV
$84.7B
| – | – |
-20,000
| Closed | -$2.88M |
|
77
PUT
iShares S&P 100 ETF
OEF
$20.4B
| – | – |
-25,000
| Closed | -$3.37M |
|
78
Regeneron Pharmaceuticals
REGN
$82.1B
| – | – |
-5,001
| Closed | -$1.84M |
|
79
Viatris
VTRS
$18.7B
| – | – |
-40,000
| Closed | -$1.61M |
|
80
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| – | – |
-10,000
| Closed | -$592K |
|
81
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
| – | – |
-15,000
| Closed | -$888K |
|
|
MYOV
82
DELISTED
Myovant Sciences Ltd.
MYOV
| – | – |
-50,000
| Closed | -$622K |
|
|
XLRN
83
DELISTED
Acceleron Pharma
XLRN
| – | – |
-60,000
| Closed | -$1.53M |
|
|
ARRY
84
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-100,000
| Closed | -$879K |
|
|
HZNP
85
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-50,000
| Closed | -$809K |
|
|
AAAP
86
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| – | – |
-60,000
| Closed | -$1.61M |
|
Similar funds
HWP
PAM
USG2
LCM
FPF
FIAS
CII
OPWM
Iguana Healthcare Management's Q1 2017 Portfolio in Review
As of Q1 2017, Iguana Healthcare Management held 86 positions worth $202M, up 21% from $167M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Iguana Healthcare Management deployed $7.29M of net new capital in Q1 2017, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was Shire pic: 61,250 shares worth $10.7M.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 76% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was Biogen, an estimated $7.07M trimmed.
- Iguana Healthcare Management's largest Q1 2017 buy was Shire pic: 61,250 shares worth $10.7M.
- Iguana Healthcare Management added most to Celgene Corp in Q1 2017, an estimated $1.2M increase.
- Iguana Healthcare Management's biggest Q1 2017 reduction was Biogen, cutting an estimated $7.07M.
- Iguana Healthcare Management fully exited Elevance Health in Q1 2017, selling an estimated $2.88M.
- Iguana Healthcare Management's ten largest holdings make up 43% of its $202M portfolio in Q1 2017.
- Iguana Healthcare Management opened 26 new positions and closed 17 in Q1 2017.
- Iguana Healthcare Management's portfolio value rose 21% quarter-over-quarter to $202M.
Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.